Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

SYMPHONY-PE Study for Treatment of Pulmonary Embolism

NCT: NCT06062329 · COMPLETED

NCT IDNCT06062329
StatusCOMPLETED
Start Date2023-12-13
Completion2025-05-29
SponsorImperative Care, Inc. (INDUSTRY)
First posted
Last updated

Brief Summary

Evaluation of the Safety and Efficacy of the Symphony Thrombectomy System in the Treatment of Pulmonary Embolism

Frequently Asked Questions

What is SYMPHONY-PE Study for Treatment of Pulmonary Embolism?

SYMPHONY-PE Study for Treatment of Pulmonary Embolism is a clinical trial registered under NCT06062329. Current status: COMPLETED.

What is the status of NCT06062329?

The current status of NCT06062329 (SYMPHONY-PE Study for Treatment of Pulmonary Embolism) is: COMPLETED.

When did SYMPHONY-PE Study for Treatment of Pulmonary Embolism start?

SYMPHONY-PE Study for Treatment of Pulmonary Embolism started on 2023-12-13.

Related Devices

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.